Biscocho, Anaquel .
HRN: 22-88-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2023
CEFUROXIME 1.5GM (VIAL)
06/12/2023
06/19/2023
IV
1.5g
Q8hx7 Days
S/P Primary LSTCS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes